Benjamin J Mandel, DDS | |
3835 Avocado Blvd #220, Lamesa, CA 91941 | |
(619) 660-0022 | |
(619) 660-2525 |
Full Name | Benjamin J Mandel |
---|---|
Gender | Male |
Speciality | Dentist - General Practice |
Location | 3835 Avocado Blvd #220, Lamesa, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1497185540 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223G0001X | Dentist - General Practice | 25420 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Benjamin J Mandel, DDS 3835 Avocado Blvd #220, Lamesa, CA 91941 Ph: (619) 660-0022 | Benjamin J Mandel, DDS 3835 Avocado Blvd #220, Lamesa, CA 91941 Ph: (619) 660-0022 |
News Archive
A team of UCLA scientists has found that the pathogen that causes leprosy has a remarkable ability to avoid the human immune system by inhibiting the antimicrobial responses important to our defenses.
Researchers in New Jersey are encouraging primary care physicians to screen for obstructive sleep apnea (OSA) in patients with Type 2 diabetes. They found that in a small sample of clinic patients, the risk for sleep apnea was high among diabetics compared with non-diabetics, and that sleep apnea appeared to be associated with carbohydrate craving.
Epocal, Inc., a leading edge provider of point of care technology, announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market its new lactate test on the epoc Blood Analysis System. Lactate measurements from the epoc System are used to evaluate acid-base status and for diagnosis and treatment of lactic acidosis (abnormally high acidity of the blood).
With a median survival rate of just five to seven years, Mantle Cell Lymphoma (MCL) is considered the most aggressive known blood cancer - and available therapies are scarce. Three thousand Americans are diagnosed with MCL every year, and despite progress in personalized therapies to treat metastases elsewhere in the body, systemic therapeutic drug delivery to cancerous blood cells continues to challenge the world of cancer research.
› Verified 9 days ago